PROPHYLACTIC EFFECTS OF NEUROLEPTICS IN SYMPTOM-FREE SCHIZOPHRENICS - ROLES OF DOPAMINERGIC AND NORADRENERGIC BLOCKERS

被引：23

作者：

NISHIKAWA, T ^{[1
]}

TSUDA, A ^{[1
]}

TANAKA, M ^{[1
]}

KOGA, I ^{[1
]}

UCHIDA, Y ^{[1
]}

机构：

[1] SEIWAKAI NISHIKAWA HOSP,HAMADA,JAPAN

来源：

BIOLOGICAL PSYCHIATRY | 1985年 / 20卷 / 11期

关键词：

D O I：

10.1016/0006-3223(85)90174-X

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

引用

页码：1161 / 1166

页数：6

共 16 条

[1] RECEPTOR ACTIVITY AND TURNOVER OF DOPAMINE AND NORADRENALINE AFTER NEUROLEPTICS [J].

ANDEN, NE ;

BUTCHER, SG ;

CORRODI, H ;

FUXE, K ;

UNGERSTEDT, U .

EUROPEAN JOURNAL OF PHARMACOLOGY, 1970, 11 (03) :303-+

[2] SCHIZOPHRENICS FULLY REMITTED ON NEUROLEPTICS FOR 3-5 YEARS - TO STOP OR CONTINUE DRUGS [J].

CHEUNG, HK .

BRITISH JOURNAL OF PSYCHIATRY, 1981, 138 (JUN) :490-494

[3]

ENGELHARDT DM, 1967, ARCH GEN PSYCHIAT, V16, P98

[4] OUTPATIENT MAINTENANCE OF CHRONIC SCHIZOPHRENIC PATIENTS WITH LONG-ACTING FLUPHENAZINE - DOUBLE-BLIND PLACEBO TRIAL - REPORT TO MEDICAL-RESEARCH COUNCIL COMMITTEE ON CLINICAL TRIALS IN PSYCHIATRY [J].

HIRSCH, SR ;

GAIND, R ;

ROHDE, PD ;

STEVENS, BC ;

WING, JK .

BRITISH MEDICAL JOURNAL, 1973, 1 (5854) :633-637

[5]

KANE JM, 1983, ARCH GEN PSYCHIAT, V40, P893

[6]

LEFF JP, 1971, BRIT MED J, V3, P559

[7] MINIMAL MAINTENANCE MEDICATION - EFFECTS OF 3 DOSE SCHEDULES ON RELAPSE RATES AND SYMPTOMS IN CHRONIC-SCHIZOPHRENIC OUTPATIENTS [J].

LEHMANN, HE ;

WILSON, WH ;

DEUTSCH, M .

COMPREHENSIVE PSYCHIATRY, 1983, 24 (04) :293-303

[8]

MELTZER HY, 1981, CLIN PHARM PSYCHIATR, P251

[9]

MIEMEGEERS CJE, 1981, ENCEPHALE, V7, P215

[10] PROPHYLACTIC EFFECT OF NEUROLEPTICS IN SYMPTOM-FREE SCHIZOPHRENICS [J].

NISHIKAWA, T ;

TSUDA, A ;

TANAKA, M ;

KOGA, I ;

UCHIDA, Y .

PSYCHOPHARMACOLOGY, 1982, 77 (04) :301-304

← 1 2 →